Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Non-Current Assets (2016 - 2025)

Bio Key International (BKYI) has disclosed Non-Current Assets for 16 consecutive years, with $6.4 million as the latest value for Q3 2025.

  • Quarterly Non-Current Assets rose 244.28% to $6.4 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $6.4 million through Sep 2025, up 244.28% year-over-year, with the annual reading at $6.7 million for FY2024, 255.09% up from the prior year.
  • Non-Current Assets hit $6.4 million in Q3 2025 for Bio Key International, down from $6.5 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $6.7 million in Q4 2024 to a low of $1.8 million in Q2 2024.
  • Historically, Non-Current Assets has averaged $3.9 million across 5 years, with a median of $3.8 million in 2021.
  • Biggest five-year swings in Non-Current Assets: soared 264.64% in 2021 and later crashed 62.5% in 2023.
  • Year by year, Non-Current Assets stood at $3.8 million in 2021, then crashed by 37.19% to $2.4 million in 2022, then decreased by 19.69% to $1.9 million in 2023, then skyrocketed by 255.09% to $6.7 million in 2024, then fell by 5.37% to $6.4 million in 2025.
  • Business Quant data shows Non-Current Assets for BKYI at $6.4 million in Q3 2025, $6.5 million in Q2 2025, and $6.6 million in Q1 2025.